Abstract
The human papillomavirus (HPV) is one of the most common viral sexually transmitted infections (STIs) in the United States. External genital warts (EGWs) are a commonly seen clinical manifestation of infection with certain strains of the HPV virus, particularly HPV types 6 and 11. Current treatments for the destruction and elimination of EGWs include in -office, provider -delivered therapy and patient -applied medications. Sinecatechins ointment 15% is the newest FDA -approved patient -applied treatment for EGWs. This article reviews the transmission and clinical presentation of EGWs, describes the use of sinecatechins ointment 15% as one patient -applied treatment option and discusses implications for nurses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
